What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Gene
- Cancer
Fumio Imazeki spends much of his time researching Hepatitis, Immunology, Internal medicine, Virology and Hepatocellular carcinoma.
His biological study deals with issues like Genetics, which deal with fields such as Physiology.
Fumio Imazeki combines subjects such as Genetic marker and Allele frequency with his study of Immunology.
His Internal medicine research is multidisciplinary, incorporating perspectives in Gastroenterology, HBsAg and Endocrinology.
His studies in Hepatocellular carcinoma integrate themes in fields like Carcinoma, Pathology, Cirrhosis and Hepatitis C.
Fumio Imazeki has researched Hepatitis B in several fields, including Chronic liver disease, Liver disease and Hepatitis B virus.
His most cited work include:
- Interferon Therapy Reduces the Risk for Hepatocellular Carcinoma: National Surveillance Program of Cirrhotic and Noncirrhotic Patients with Chronic Hepatitis C in Japan (963 citations)
- Histologic Improvement of Fibrosis in Patients with Hepatitis C Who Have Sustained Response to Interferon Therapy (656 citations)
- Incidence of hepatocellular carcinoma in chronic Hepatitis B and C: A prospective study of 251 patients (388 citations)
What are the main themes of his work throughout his whole career to date?
Fumio Imazeki focuses on Virology, Internal medicine, Gastroenterology, Immunology and Hepatitis C virus.
Virology is frequently linked to Genotype in his study.
His Chronic hepatitis research extends to the thematically linked field of Internal medicine.
Many of his research projects under Gastroenterology are closely connected to In patient with In patient, tying the diverse disciplines of science together.
His study in Liver biopsy extends to Immunology with its themes.
The concepts of his Hepatitis C virus study are interwoven with issues in Interferon, Hepatitis C and Adverse effect.
He most often published in these fields:
- Virology (40.98%)
- Internal medicine (34.10%)
- Gastroenterology (26.23%)
What were the highlights of his more recent work (between 2010-2021)?
- Internal medicine (34.10%)
- Gastroenterology (26.23%)
- Virology (40.98%)
In recent papers he was focusing on the following fields of study:
His main research concerns Internal medicine, Gastroenterology, Virology, Hepatitis C virus and Immunology.
Fumio Imazeki interconnects Autoimmune hepatitis, Chronic hepatitis, Hepatitis C and Liver biopsy in the investigation of issues within Gastroenterology.
The study incorporates disciplines such as Genotyping and Genotype in addition to Virology.
His Hepatitis C virus study combines topics in areas such as Interferon and Adverse effect.
His Immunology study combines topics from a wide range of disciplines, such as Chronic liver disease and Anemia.
His Hepatitis B virus research is multidisciplinary, relying on both Hepatitis B and Risk factor.
Between 2010 and 2021, his most popular works were:
- 3-Deazaneplanocin A is a promising therapeutic agent for the eradication of tumor-initiating hepatocellular carcinoma cells (85 citations)
- Subthalamic deep brain stimulation can improve gastric emptying in Parkinson’s disease (69 citations)
- Rikkunshito improves the symptoms in patients with functional dyspepsia, accompanied by an increase in the level of plasma ghrelin. (63 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Gene
- Cancer
Fumio Imazeki mainly investigates Internal medicine, Virology, Immunology, Hepatitis B virus and Hepatitis C virus.
His studies deal with areas such as Gastroenterology and Endocrinology as well as Internal medicine.
His study in Gastroenterology is interdisciplinary in nature, drawing from both Transplantation, Etiology and Fulminant hepatitis.
He has included themes like Toll-like receptor, Retrospective cohort study, Genotype and Cell biology in his Virology study.
His study in Immunology concentrates on Antibody and Interferon.
Antigen is closely connected to Hepatitis B in his research, which is encompassed under the umbrella topic of Hepatitis B virus.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
